The emergence of cell therapy is rapidly changing the healthcare landscape. Our Cell and Gene Therapy business provides the tools, technology and processes to enable customers to achieve their goals. We are investing in the field for the long-term, and partnering with pharma, biotech and clinical researchers. GE brings expertise in quality, global distribution, R&D, and regulatory that will transform cell therapy to a globally-accessible personalized medicine.